浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2014年
24期
1993-1996
,共4页
鼻咽癌%细胞因子%预后%放化疗
鼻嚥癌%細胞因子%預後%放化療
비인암%세포인자%예후%방화료
Nasopharyngeal carcinoma%Cytokines%Prognosis%Chemoradiotherapy
目的评价治疗前血清Th1细胞因子(IL-2、TNF-α和IFN-γ)浓度在鼻咽癌放化疗中对患者远期生存的影响。方法使用流式细胞小球微阵列术检测80例鼻咽癌患者治疗前血清Th1细胞因子水平,使用Kaplan- Meier法绘制生存曲线,使用COX回归法分析细胞因子水平与患者总生存(OS)之间的关系。结果非角化性鼻咽癌上IFN-γ水平较角化性癌升高(P=0.012);Th1细胞因子水平与患者放化疗治疗效果差异无统计学意义(P>0.05),治疗前TNF-α高浓度组患者预后明显不如低浓度组(P=0.015),治疗前IL-2高浓度组患者预后明显好于低浓度组(P=0.048)。结论鼻咽癌患者治疗前TNF-α及IL-2水平是预后的独立预测因素。
目的評價治療前血清Th1細胞因子(IL-2、TNF-α和IFN-γ)濃度在鼻嚥癌放化療中對患者遠期生存的影響。方法使用流式細胞小毬微陣列術檢測80例鼻嚥癌患者治療前血清Th1細胞因子水平,使用Kaplan- Meier法繪製生存麯線,使用COX迴歸法分析細胞因子水平與患者總生存(OS)之間的關繫。結果非角化性鼻嚥癌上IFN-γ水平較角化性癌升高(P=0.012);Th1細胞因子水平與患者放化療治療效果差異無統計學意義(P>0.05),治療前TNF-α高濃度組患者預後明顯不如低濃度組(P=0.015),治療前IL-2高濃度組患者預後明顯好于低濃度組(P=0.048)。結論鼻嚥癌患者治療前TNF-α及IL-2水平是預後的獨立預測因素。
목적평개치료전혈청Th1세포인자(IL-2、TNF-α화IFN-γ)농도재비인암방화료중대환자원기생존적영향。방법사용류식세포소구미진렬술검측80례비인암환자치료전혈청Th1세포인자수평,사용Kaplan- Meier법회제생존곡선,사용COX회귀법분석세포인자수평여환자총생존(OS)지간적관계。결과비각화성비인암상IFN-γ수평교각화성암승고(P=0.012);Th1세포인자수평여환자방화료치료효과차이무통계학의의(P>0.05),치료전TNF-α고농도조환자예후명현불여저농도조(P=0.015),치료전IL-2고농도조환자예후명현호우저농도조(P=0.048)。결론비인암환자치료전TNF-α급IL-2수평시예후적독립예측인소。
Objective To investigate the correlation of serum Th1 cytokine levels with long- term survival of patients with nasopharyngeal carcinoma(NPC). Methods Pretreatment serum Th1 cytokines IFN- γ, TNF- αand IL- 2 were detected by cy-tometric bead array(CBA) method in 80 NPC patients undergoing chemoradiotherapy. The survival of patients was measured by Kaplan- Meier curve. The association between cytokine levels and the overal survival (OS) of patients were evaluated with Cox regression analysis. Results Serum IFN- γ levels in patients with non- keratinizing carcinoma were higher than that with kera-tinizing carcinoma (P=0.012). The pretreatment serum IFN- γ, TNF- α and IL- 2 levels were not significantly correlated with treatment response (P>0.05) adjusted for age, gender, TNM stage and tumor cel histology of patients. Higher pretreatment serum TNF- α levels were significantly associated with poorer survival (P =0.015). Patients with a higher pretreatment serum IL- 2 levels had a significantly longer survival than patients with lower levels(P=0.048). Conclusion High serum TNF- level and low IL- 2 level may predict unfavorable prognosis in patients with NPC.